Human p29 is a chromatin-associated protein and the silencing of p29 expression increases cell population in G 1 phase and decreases phosphorylation levels of Chk1 and Chk2 in response to UV treatment. To further characterize the function of p29, U2OS and Fanconi anemia complementation group G (FA-G) cells with constitutive p29 expression have been established. Analyses of these cells identified increased phosphorylation levels of Chk1 and Chk2, which were accompanied by elevated amounts of chromatinassociated Mre11-Rad50-Nbs1 complex and ATR-IP. Monoubiquitination of the FA ID complex was restored in p29 stably expressing FA-G cells. Moreover, lower tumor incidence was observed in mp29 transgenic mice after UV irradiation. These results suggest the involvement of p29 in the DNA damage responses and Fanconi anemia pathway.
Introduction
To maintain the genome integrity, cells trigger multiple cellular responses whenever their DNA molecules are damaged. DNA breakages are detected by sensor proteins, such as Rad9-Rad1-Hus1 (9-1-1), Mre11-Rad50-Nbs1 (MRN), ataxia telangiectasia mutated (ATM) and ataxia-telangiectasia and Rad3-related (ATR), with the aid of mediators, like MDC1, Claspin, 53BP1 and BRCA1. The activated ATM/ATR kinases deliver the signal to transducers, Chk1 and Chk2, which can then activate or inactivate effectors, such as p53 and Cdc25 that directly participate in inhibiting the G 1 /S transition, S-phase or G 2 / M transition until the damage is repaired or apoptosis is invoked (1) (2) (3) .
It is well known that the induction of double-strand breaks leads to recruitment of the MRN complex, which forms a bridge between broken DNA ends and inactive ATM kinase. ATM dimers undergo autophosphorylation on Ser367, Ser1893 and Ser1981, which result in conversion from an inactive dimer to an active monomer. This leads to the phosphorylation of its downstream substrates, such as Chk2 and p53 (4) (5) (6) . The activation of ATR primarily occurs at a stalled replication fork. Upon encountering a replication-blocking lesion, ssDNA-RPA recruits ATR-ATR-interacting protein (ATRIP), Rad17/RFC and 9-1-1 complexes to the stalled replication fork. Phosphorylated TopBP1 (topoisomerase II binding protein 1) can bind ATR and AT-RIP, resulting in ATR activation to phosphorylate downstream effectors including Chk1 (7) (8) (9) . Chk1 and Chk2 are structurally unrelated yet functionally overlapping serine/threonine kinases. The key mission of Chk1 and Chk2 is to relay the checkpoint signals from ATM and ATR to their downstream effectors. The original concept of a strict dependence of Chk1 on ATR and Chk2 on ATM has been challenged by recent reports that there is a degree of crosstalk between these kinases. UV and hydroxyurea, both potent activators of ATR signaling, activate ATM in an ATR-dependent manner (10) . Studies have also shown that ATM can phosphorylate Chk1 in cells exposed to ionizing radiation (IR) treatment, although this occurs to a lesser extent than the ATR-mediated effect. In addition, both ATR and ATM target the SQ-rich C terminus of Chk1 on serine 317 and 345 and this lead to Chk1 activation (11, 12) .
Fanconi anemia (FA) is a rare autosomal or X-linked recessive hereditary disorder with developmental defects, progressive bone marrow failure and a severe cancer predisposition. Cells derived from FA patients show a high sensitivity to DNA cross-linking agents, such as mitomycin C and cisplatin. It is known that the FA complex is composed of 13 genes, including A, B, C, D1 (BRCA2), D2, E, F, G, I, J, L, M and N. Eight of FA proteins (FANCA/B/C/E/F/G/L/M) are found in the nuclear FA core complex and required for the monoubiquitination of FANCD2 and FANCI (the FA ID complex) (13) (14) (15) (16) . FANCL is an E3 ubiquitin ligase that is probably responsible for the monoubiquitination of FANCD2 (17) . This monoubiquitination event occurs during a normal unperturbed S-phase or follows an induction of DNA doublestrand breaks and interstrand DNA cross-links. DNA lesions arising during normal S-phase or after DNA damage activate ATR-dependent phosphorylation and FA core complex-dependent monoubiquitination of FA ID complex. The monoubiquitinated ID complex forms nuclear foci that recruit DNA repair proteins in order to promote homologous recombination allowing for DNA repair (13) (14) (15) (16) .
p29 was initially identified as a GCIP (grap2 cyclin-D interacting protein) interacting protein by yeast two-hybrid screening (18) . Genetic screening and biochemical studies indicate that Syf2, the p29 ortholog in Saccharomyces cerevisiae, appears to be part of the cell cycle and splicing complex, which is involved in cell cycle progression and pre-mRNA splicing. Mutation of Syf2 leads to cell cycle arrest at the G 2 /M phase boundary (19, 20) . In contrast, p29 affects DNA damage response (DDR) with UV irradiation. Depletion of p29 results in a decrease in Chk1 activity and premature chromatin condensation after UV irradiation. p29 deficiency also downregulates UV-induced ATM phosphorylation at S1981 in HeLa cells (21) .
In this study, we analyzed the cellular responses to DNA damage in p29 stably expressing U2OS and Fanconi anemia complementation group G (FA-G) cells. We also generated mp29 transgenic mice and examined the effects of p29 on DDR in vivo. We here described novel functions for p29 in the DDR and FA pathway.
Materials and methods

Cell culture
HeLa cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal bovine serum. U2OS and HCT116 cells were grown in McCoy's 5A medium with 1.5 mM glutamine and 10% fetal bovine serum. Human SV-40-immortalized fibroblast FA-G (GM16635) and fibroblast FA-D2 (GM16633) from Coriell Cell Repositories were maintained in MEM (minimum essential medium) Alpha modification medium supplemented with 10% fetal bovine serum.
Antibodies
Rabbit anti-Chk1, pChk1S317, Chk2, pChk2T68, p53, pp53S15, pp53S20, Mre11 and NBS1 antibodies were purchased from Cell Signaling Technology (Beverly, MA). Rabbit anti-p21, Bax, Bcl-2, Rad50, FANCA, FANCC, FANCG and FANCL antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-FANCD2 antibody was purchased from Novus Biologicals (Littleton, CO). Rabbit anti-FANCI was obtained from Bethyl Lab (Montgomery, TX). Mouse anti-a-tubulin was from Sigma-Aldrich (St Louis, MO). Small interfering RNA The small interfering RNA duplexes, sip29-1 and sip29-2, were designed corresponding to the coding regions 92-112 and 440-460 nucleotides relative to the start codon of p29 (GenBank accession no. AF273089) and transfection was conducted as described previously (21) .
Detection of apoptotic cells
Apoptotic cells were labeled with fluorescein isothiocyanate-conjugated Annexin V (Sigma-Aldrich) and propidium iodide for 15 min in the dark and analyzed by FACSCalibur (Becton Dickinson, Mountain View, CA).
Lentivirus production
The packaging vector pCMVdeltaR8.91, the vesicular stomatitis virus G protein (VSV-G) envelope glycoprotein-expressing vector pMD.G and the full-length of p29 in the pLenti6/V5-D-TOPO vector (Invitrogen, Carlsbad, CA) were co-transfected into HEK 293T cells. After 48 h incubation, the supernatant medium was centrifuged to collect viral particles. Polybrene (8 lg/ml) was added to facilitate viral infection in U2OS, FA-G and FA-D2 cells. Stable clones were selected using blasticidine (Invitrogen) for 21 days.
Cell manipulation
Whole-cell extracts, nuclear extracts and chromatin-bound extracts, immunofluorescence and transfection were performed as described previously (21) .
Generation of mp29 transgenic mice
Mouse mp29 complementary DNA containing the entire coding region was inserted into a mouse PGK1 promoter-driven expression vector and microinjected into the pronucleus of FVB/NCrlNarl mice-fertilized mouse eggs.
Eggs were transferred to the oviduct of pseudopregnant female CbyB6F1 mice. The founders were identified by polymerase chain reaction for genotyping. Transgenic mice and control mice were propagated by breeding mp29 heterozygote transgenic males with wild-type FVB females. All animal studies were performed in accordance with the guidelines of the Institutional Animal Use and Care Committee at National Taiwan University (Protocol #97017).
UV irradiation UV light was delivered by the UV Stratalinker 2400 (Stratagene, La Jolla, CA). Hairs on the back were removed before UV treatment and mice were exposed to 5000 J/m 2 of UV light three times every week until all wild-type FVB mice had skin tumors, approximately at 42 weeks after UV irradiation.
Results
p29 stably expressing U2OS cells were resistant to UV irradiation U2OS cells were transduced with control (empty vector: Lenti6/V5) and p29 Lentivirus and two independent clones (Lenti-p29-5 and Lenti-p29-10) with high p29 expression levels were confirmed by immunoblotting ( Figure 1A ) and immunofluorescence analysis (supplementary Figure 1 is available at Carcinogenesis Online). We then examined whether the constitutive expression of p29 could affect cell cycle progression after UV irradiation. Cells were irradiated with 10 J/ m 2 UV light and sampled at various time points for measuring DNA contents. At 8 and 12 h after UV treatment, an increased population in S-phase was observed in p29 stably expressing cells. At 48 h post-UV Stable expression of p29 in U2OS and FA-G cells irradiation, $15% of control cells were in the sub-G 1 . This contrasted with ,5% of the sub-G 1 population in p29 stably expressing U2OS cells ( Figure 1B ). The clonogenic survival assay showed that control U2OS cells displayed less surviving colonies compared with the p29 stably expressing cells after UV irradiation ( Figure 1C ). Furthermore, Annexin V staining also supported the above observation (supplementary Figure 2B is available at Carcinogenesis Online). Together, these results suggested that UV-triggered apoptosis was inhibited when p29 was constitutively expressed.
p29 affected phosphorylation levels of Chk1 and Chk2
To investigate which component in DDRs was affected, whole-cell extracts were prepared for immunoblotting analysis. The phosphorylation level of Chk2 on T68, which was normalized with the total amount of Chk2 protein, increased in p29 stably expressing cells after 10 J/m 2 UV treatment (Figure 2A and B) . Intriguingly, although the whole phosphorylation level of Chk1 on S317 was elevated, 10 J/m 2 UV light was not sufficient to increase a normalized Chk1 phosphorylation ( Figure 2B ). Nonetheless, we did detect a higher normalized Chk1 phosphorylation on S317 with 50 J/m 2 UV irradiation in p29 stably expressing cells compared with control cells (supplementary Figure 3A and B is available at Carcinogenesis Online). Consequently, the phosphorylation of p53, a downstream target of Chk2, on S20 was induced (Figure 2A and B). The immunofluorescence result showed an accumulation of p53 in the nucleus, further supporting our observations (supplementary Figure 4 is available at Carcinogenesis Online). Interestingly, p21, a downstream target of p53, was not increased, which might explain why there was no G 1 accumulation in p29 stably expressing U2OS cells. Bax, another downstream target of p53, was not changed, indicating that the accumulation of p53 did not facilitate to promote apoptosis. Instead, the expression of Bcl-2 was induced in p29 stably expressing cells (Figure 2A ), rendering cells more resistant to UV irradiation. To investigate whether the chromosome integrity was protected in p29 stably expressing cells, we analyzed chromosome lesions after UV irradiation using the comet assay. Approximately 80% of control cells treated with UV light showed damaged and fragmented DNA with distinct tails. In contrast, only 10% of p29 stably expressing cells had similar tailed migration patterns (supplementary Figure 5A is available at Carcinogenesis Online). Additionally, metaphase spreads showed less chromosome breakages after UV or mitomycin C (MMC) treatment both in p29 stably expressing U2OS and FA-G cells (supplementary Figure 5B is available at Carcinogenesis Online), supporting the contention that an increased p29 expression activated DDRs to maintain chromosome integrity.
Since the activation of ATM kinase is highly dependent on the MRN complex and it is known that ATRIP and TopBP1 are required for ATR activation, we checked if the amounts of these proteins in chromatin-bound fraction were increased. As anticipated, Mre11, Rad50 and Nbs1 were increased in the chromatin-bound fraction when cells treated with 10 J/m 2 UV light, whereas ATRIP was increased with 50 J/m 2 UV irradiation ( Figure 2C and supplementary Figure 3C is available at Carcinogenesis Online), suggesting that ATM and ATR might be activated due to an increment of these sensor proteins bound onto the chromatin.
p29 knockdown affected the monoubiquitination of FA ID complex The ATR-Chk1 pathway has been shown to promote the monoubiquitination of FANCD2 (16) . To test whether p29 was involved in FA pathway, HeLa cells were pre-treated with CSK (cytoskeletal buffer) and immunostained with p29 and FANCD2 antibodies. Interestingly, p29 colocalized with FANCD2 in the S-phase, but not in the G 1 phase, and in cells treated with UV and IR irradiation, indicating that p29 might associate with the FA complex in unperturbed S-phase and in damaged cells ( Figure 3A) . We examined whether p29 and FANCD2 were in the same immunocomplex. Chromatin-bound fraction prepared from S-phase arrested cells and UV-irradiated cells were immunoprecipitated with p29, FANCD2 or control antibodies. Immunoblotting analysis revealed that p29 and FANCD2 were in the same immunocomplex either in cells during the S-phase or in cells after UV treatment ( Figure 3B ). We further checked whether the depletion of p29 affected the monoubiquitination of FA ID complex. Immunoblotting analysis showed that the monoubiquitination levels of FA ID complex were reduced in response to UV, MMC and hydroxyurea treatments in p29-depleted cells (Figure 3C ), suggesting that the silencing of p29 could affect the FA pathway by downregulating the monoubiquitination of FA ID complex. Furthermore, p29-depleted cells were sensitive to MMC treatment in contrast to the control HeLa cells transfected with luciferase small interfering RNA (supplementary Figure 6 is available at Carcinogenesis Online). Taken together, these results suggest that a critical amount of p29 might be required for the monoubiquitination of FA ID complex to promote DNA damage repair.
The restoration of the monoubiquitination of FA ID complex by stable expression of p29 in FA-G cells To check if p29 interacts with FA core complex, we constructed FANCA, FANCC, FANCD2, FANCE, FANCF, FANCG and FANCL for the yeast two-hybrid analysis. p29 was found to interact with FANCG but not with any of the other FA subunits. However, no successful GST Stable expression of p29 in U2OS and FA-G cells (glutathione S-transferase) pull down or co-immunoprecipitation experiments could further support the yeast two-hybrid result (data not shown), suggesting a weak or transient interaction between p29 and FANCG in vivo. To test whether p29 complemented the defective DDR in FA-G cells, p29 was transduced to FA-G cells and stable clones (Lenti-p29-3 and Lenti-p29-15) were selected. Immunoblotting analysis showed that monoubiquitination of FANCD2 was restored before MMC or UV treatment even in the absence of FANCG protein (Figure 4A ), implying that a constitutive expression of p29 might result in the recruitment of the FA core complex onto chromatin to reproduce FANCD2 monoubiquitination. Since monoubiquitination of FANCD2 is dependent on ATR and FA core complex, we examined if ATR pathway was activated and the amounts of chromatin-bound FA core complex were elevated. Similar to U2OS cells, the phosphorylation of Chk1 and Chk2 as well as the amount of ATRIP were increased in p29 stably expressing FA-G cells. Interestingly, the amounts of chromatin-associated FANCI and FANCL molecules were greatly increased. In contrast, no significant difference was found in the amounts of FANCA and FANCC, indicating that the increased amounts of FANCI and FANCL might facilitate the monoubiquitination of FANCD2 in response to UV treatment ( Figure 4B ). Furthermore, a cell viability assay showed that the parental and control FA-G cells were sensitive to MMC treatments. In contrast, the p29 stably expressing FA-G cells were remarkably resistant to MMC treatments ( Figure 4C ). Similar results were found in cells treated with cisplatin (supplementary Figure 7 is available at Carcinogenesis Online), suggesting that p29 upregulated monoubiquitination of FA ID complex to promote DNA repair. The comet assay and metaphase spread also showed that chromosome DNA remained within the nucleus and the number of aberrant chromosomes (breaks and radials) was much less observed in p29 stably expressing cells treated with MMC (supplementary Figure 5 is available at Carcinogenesis Online). However, the stable expression of p29 in FA-D2 cells did not complement the sensitivity to MMC treatment ( Figure 4D ), suggesting that p29 plays a role upstream of FA ID complex.
Resistance of UV irradiation in mp29 transgenic mice
We hypothesized that an upregulated expression of murine mp29 protein may affect DDRs with UV irradiation. An expression vector harboring mp29 complementary DNA under the control of mouse PGK-1 promoter was constructed and this transgene construct was microinjected into FVB zygotes to generate mp29 transgenic founders, #7 and #17. F1 newborn pups carrying þ/þ and Tg/þ genotypes were established by breeding founders to the wild-type FVB ( Figure 5A ). Immunoblotting showed that the expression of mp29 was elevated in the crude tissue extracts prepared from the brain, kidney, spleen, liver and testis of mp29 Tg/þ transgenic mice (supplementary Figure 8A is available at Carcinogenesis Online). No significant phenotypic differences were observed between F1 wild-type and mp29 transgenic mice (supplementary Figure 8B is available at Carcinogenesis Online). To investigate whether mp29 transgenic mice were resistant to UV-induced damages, wild-type and mp29 Tg/þ mice were exposed to 5000 J/m 2 UV light three times every week. Irradiated mice began to have oval papules on the skin surfaces and nodular skin tumor emerged approximately at 24 weeks in wild-type and 26 weeks in mp29 transgenic mice post-UV treatment. Averagely, mp29 transgenic mice had smaller sizes and fewer amounts of nodular tumors than those of wild-type mice after 38 weeks treatment ( Figure 5B ). Histological examinations revealed features as squamous cell carcinomas occurred both in wild-type and mp29 transgenic mice (supplementary Figure 8C is available at Carcinogenesis Online). Totally, the mp29 transgenic mice had lower incidence of skin tumors compared with control wild-type mice ( Figure 5C ), suggesting that mp29 transgene protected these mice from UV irradiation and further supporting the results of p29 in U2OS and FA-G cells.
Discussion
On the basis of these experiments, we conclude that the function of p29 in U2OS and FA-G cells has several impacts on DDRs. First, the stable expression of p29 promotes the binding of the MRN complex (10 J/m 2 UV irradiation) and ATRIP (50 J/m 2 UV irradiation) to chromatin that may then activate ATM and ATR and result in the phosphorylation of downstream targets, such as Chk1 and Chk2. Second, critical amounts of p29 support the chromatin association of FANCI and FANCL that seems to restore the monoubiquitination of FA ID complex in FA-G cells. This renders cells resistant to UV and MMC treatments (Figure 6 ).
The activation of Chk1 in S-phase delays DNA replication, stabilizes replication forks and blocks mitotic entry to maintain genome integrity. It has been suggested that ATM/ATR-dependent release of Chk1 from chromatin promotes the DNA damage checkpoint response (22) . The dissociation of Chk1 from chromatin results in a reduced phosphorylation of Histone H3 on T11 and induces transcriptional repression following DNA damage (23) . In contrast, Chk2 is central to transducing the DNA damage signal from ATM to its downstream targets, like p53. The ATM-Chk2-p53 cascade prevents cells from aberrant proliferation. One of the mechanisms of keeping p53 at a low level in resting cells is through the action of MDM2, an E3 ligase responsible for p53 degradation. Upon responding to a variety of stresses, such as IR, UV or replication stress, p53 can be phosphorylated on Ser15 by ATM and Ser20 by Chk2 and these two phosphorylation events could disrupt the interaction with MDM2 and stabilize p53 (24) . Tail DNAs extracted from newborn pups were subjected to polymerase chain reaction analysis using mPGKF1/mp29R1 as primers. Lane1: pGKmp29 plasmid was used as a positive control; Lane 2-3: mp29 Tg #7 heterozygotes; Lane 4-5: mp29 Tg #17 heterozygotes and Lane 6-10: wild-type FVB mice. (B) Wild-type FVB and mp29 Tg/þ mice were irradiated with 5000 J/m 2 UV light three times every week. Nodular skin tumors appeared in wild-type and mp29 transgenic mice at 34 weeks post-UV irradiation. (C) Tumor incidence was calculated by two independent experiments with a total animal size of n 5 27 for wildtype (WT) and n 5 29 for mp29 transgenic mice (Tg). The tumor incidence was defined as 100% when all of wild-type mice had skin tumors, approximately at 42 weeks after UV treatment.
The responses in p29 stably expressing U2OS and FA-G cells are largely in accordance with ATM/ATR-signaling pathway, where Chk1 and Chk2 were activated and p53 was phosphorylated, possibly resulting from the increased chromatin-bound levels of the MRN complex and ATRIP ( Figure 2C and supplementary Figure 3C is available at Carcinogenesis Online). Although the earliest step in the DDR is due to the recognition of DNA lesions by sensor proteins before the initiation of a rapid accumulation of DNA checkpoint and repair factors to the damage sites, it has been reported that a prolonged binding of DNA repair components, such as NBS1, Mre11, MDC1 and ATM, to chromatin can elicit the DDR in an ATM and DNA-PKdependent manner in the absence of DNA lesions (25) . Furthermore, phosphorylation of key components in DDR, including H2AX, NBS1 and ATM, are able to amplify DNA damage-signaling cascade by tethering other complexes to chromatin (25) . Very recently, studies showed that loss of HMGN1, a member of high mobility group superfamily, or ablation of its ability of binding to chromatin reduces the levels of IR-induced ATM autophosphorylation and the activating of several ATM targets, identifying a new mediator of ATM activation by histone modification (26) . In this report, we observed the phosphorylation levels of Chk1 and Chk2 were increased, but the phosphorylation of H2AX was not increased in p29 stably expressing cells (supplementary Figure 3 is available at Carcinogenesis Online), suggesting that the adjacent kinase ATM/ATR did not phosphorylate H2AX to mediate the signaling cascade. Instead, Chk1 and Chk2 became the major players to deliver ATM/ATR signaling. Because H2AX phosphorylation was not increased and there was no fragmented DNA in individual cells in comet assay, we conclude that p29 activated the ATM/ATR cascade under a circumstance that no DNA breakage is produced.
FANCM/FAAP24 binds to chromatin with a higher binding affinity to Y-shaped DNA during DNA replication and after DNA damage. FANCM/FAAP24 recruits the FA core proteins to sites of DNA damage. The FA core complex is essential for the monoubiquitination of FANCD2 and FANCI (27, 28) . Subsequently, DNA repair proteins responsible for homologous repair and translesion repair, such as BRCA2, rad51 and BRCA1, are recruited to facilitate the replacement of aberrant DNA lesions (16) . Crosstalk between ATR and FA pathway has been suggested. Biochemical studies showed that a stalled replication fork activates ATR and Chk1 to phosphorylate FA core and ID complex. ATR-deficient Seckel cells are defective in the MMCinduced monoubiquitination of FANCD2 (29) , indicating that ATR kinase is required for an efficient FANCD2 monoubiquitination. Alternatively, Chk1 mediates phosphorylation of FANCE on T346/ S374. A non-phosphorylated mutant form of FANCE allows FANCD2 monoubiquitination, foci assembly and normal S-phase progression but fails to complement the mitomycin C hypersensitivity in FA-E cells (30) , indicating that Chk1-mediated phosphorylation of FANCE is required for a function independent of FANCD2 monoubiquitination. In our results, p29 colocalized with FANCD2 after UV and IR treatment and the depletion of p29 decreased the monoubiquitination of FA ID complex (Figure 3) . The constitutive expression of p29 in FA-G cells dramatically restored the monoubiquitination of FA ID complex and rendered cells to mitomycin C resistance. This effect was not observed in FA-D2 cells ( Figure 4D ), placing p29 upstream of FA ID complex in FA pathway. Nevertheless, we did not observe an increased monoubiquitinated FANCD2 ratio in p29 stably expressing U2OS cells compared with control cells (supplementary Figure 9 is available at Carcinogenesis Online). This raises an intriguing speculation that the stable expression of p29 may not regulate FA pathway in cells with normal and intact FA core components. In fact, our preliminary data showed little effect on the monoubiquitination of FA ID complex in p29 stably expressing colon cancer HCT116 cells (data not shown), which contains wild-type FA core components, further supporting this speculation.
The integrity of the genome is continuously threatened by a variety of endogenous and environmental agents. Repeated exposure to UV irradiation results in several types of mutagenic photoproducts. Cyclobutane pyrimidine dimmers and 6-4 photoproducts are two major types of DNA lesions, which predominantly lead to C/T and CC/TT mutations, induced by UV irradiation (31) . These changes eventually overwhelm DNA repair pathway that leads to squamous or basal cell carcinoma (32) . Recent investigations have suggested that oncogene-driven cell divisions will trigger DDRs and form a barrier to prevent aberrant cell proliferation. Thus, phosphorylated ATM, Chk2, H2AX and p53 can be detected in early stages of human tumors of urinary bladder, breast, lung and colon in clinical specimens (33) . Furthermore, DDRs, including phosphorylated Chk2, p53 and A schematic model for p29 in the DNA damage checkpoint pathway. In U2OS and FA-G cells, the overexpression of p29 results in increased phosphorylation of Chk1 and Chk2. This is most probably mediated by elevated chromatin-bound MRN complex and ATRIP to activate ATM and ATR, respectively. In FA-G cells, the increased amount of p29 recruits FANCL to the chromatin and elevates monoubiquitination of FANCD2 and FANCI.
Stable expression of p29 in U2OS and FA-G cells H2AX, were observed in preneoplastic and neoplastic lesions (34) . These data suggested that cancer cells have to surmount DDR barriers to create the genomic instability needed for cancer evolution. The biological significance of p29 overexpression in vivo was suggested by the resistance to UV irradiation in mp29 transgenic mice. The resistance of mp29 transgenic mice to UV irradiation suggests a role of p29 forming a barrier for skin tumorigenesis. It would be of interest to investigate whether p29 is clinically relevant to skin tumor formation and progression. Unfortunately, our anti-p29 antibodies are not suitable for immunohistochemical studies. Nevertheless, examinations of p29 protein levels in normal, dysplastic, hyperplastic and carcinoma cells would reveal a role of p29 in tumorigenesis. Supplementary Figures 1-9 can be found at http://carcin.oxfordjournals. org/ Funding National Science Council (NSC 95-2311-B-002-031-MY3); National Taiwan University (97-R0066-33) to M.S.C.
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